Individual athletes with large STVQT could be then subjected to more detailed and sophisticated examinations (e.g. evaluation of possible mutations in potassium channel protein encoding genes) to carefully evaluate their vulnerability to ventricular arrhythmias and sudden cardiac death. The gene discussed is KCNQ5; the disease is Ventricular arrhythmia.